Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
36.54
-0.04 (-0.11%)
At close: Aug 1, 2025, 4:00 PM
36.55
+0.01 (0.03%)
After-hours: Aug 1, 2025, 4:00 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $403.97 million as of August 1, 2025.
Market Cap
403.97M
Enterprise Value
336.75M
1-Year Change
n/a
Ranking
Category
Stock Price
$36.54
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $403.97M, an increase of 180.60%. That is a compound annual growth rate of 425.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 404.42M | 200.33% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.67B |
| Johnson & Johnson | 405.93B |
| AbbVie | 336.29B |
| UnitedHealth Group | 238.48B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 224.63B |
| Novo Nordisk | 221.96B |